Skip to content

Ovarian Hyperstimulation and Fibrin Clot Properties.

The Impact of Different Ovarian Hyperstimulation Protocols on Coagulation and Fibrinolysis.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04166825
Enrollment
300
Registered
2019-11-18
Start date
2019-11-18
Completion date
2026-01-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, Fibrin Blood Clot, Infertility, Female

Keywords

coagulation, fibrinolysis, ovarian hyperstimulation, infertility

Brief summary

The impact evaluation of ovarian hyperstimulation on coagulation and fibrinolysis in infertile women. Comparative analysis between different ovarian stimulation protocols on thrombin formation and efficiency of fibrinolysis in women diagnosed with infertility.

Detailed description

Infertility is a common problem. Assisted reproductive techniques (ART) increases the chance of getting pregnant by couples undergoing such treatment. Unfortunately, the numer of live births after ART remains still low. Over the past three decades, physicians have tried to improve infertility diagnosis and increase its successful treatment. An effort aimed at increasing effectivenes of diagnosis resulted in hypothesis that one of probable reasons of infertility may be the occurrence of microclots, which worsen implantation and embryos development. There are currently no published studies describing the effects of different ovarian hyperstimulation protocols on hemostasis (coagulation and fibrinolysis). The parameters of thrombin generation and efficiency of fibrinolysis will be evaluated in women qualified for ovarian hyperstimulation. The study may improve the effectiveness of ART.

Interventions

DIAGNOSTIC_TESTfibrin clot properties

Assessment of thrombin generation and efficiency of fibrinolysis.

Sponsors

Jagiellonian University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* infertility defined based on the WHO 2010 criteria

Exclusion criteria

* ovarian involvement * oral contraceptives use within previous 3 months * dienogest therapy within 3 months until ART * thrombotic events in the medical history * severe hypertension * diabetes mellitus * the presence of known VTE risk factors, including obesity, recent major surgery with prolonged immobilization or trauma, * deficiency of antithrombin, protein C or protein S, * antiphospholipid syndrome, * known malignancy, * any chronic inflammatory diseases (e.g. rheumatoid arthritis) * advanced chronic renal disease (estimated glomerular filtration rate \[eGFR\] \<30 ml/min), * international normalized ratio (INR) more than 1.2 at the day of blood draw * pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Fibrin clot properties before and after the ovarian hyperstimulation.4 monthsCoagulation (endogenous thrombin potential) and fibrinolysis (F1+2, clot lysis time)parameters assessment.

Secondary

MeasureTime frameDescription
Endometriosis and fibrin clot properties.1 cycleChanges of fibrin clot properties before and after ovarian hyperstimulation in women with endometriosis - Coagulation (endogenous thrombin potential) and fibrinolysis (F1+2, clot lysis time)parameters assessment.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026